(Q41716386)

7 October 2017

1 reference

title

Non-insulin dependent diabetes in children and adolescents: the therapeutic challenge (English)

1 reference

7 October 2017

K L Jones

1

1 reference

7 October 2017

publication date

1 February 1998

1 reference

7 October 2017

1 reference

7 October 2017

volume

37

1 reference

7 October 2017

issue

2

1 reference

7 October 2017

page(s)

103-110

1 reference

Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr.

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Insulin-sensitive and insulin-resistant variants in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

The pathogenesis of NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Type II diabetes mellitus and polymorphism of insulin-receptor gene in Mexican Americans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Insulin resistance in the pathogenesis of NIDDM in Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Nutrition principles for the management of diabetes and related complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Nibbling versus gorging: metabolic advantages of increased meal frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Scope and heterogeneous nature of MODY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Role of metformin in treatment of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Acarbose : An Update of its Pharmacology and Therapeutic Use in Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Clinical review 26: Insulin resistance in obese and nonobese man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

21 January 2018

Evening insulin strategy

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

21 January 2018

Insulin use in NIDDM.

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Insulin use in NIDDM. Rationale based on pathophysiology of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

21 January 2018

Oral hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1177%2F000992289803700207

10.1177/000992289803700207

21 January 2018

Identifiers

DOI

1 reference

7 October 2017

1 reference